The Patent Finder

Intron Biotechnology, Inc.

Also on record
Records under this name other than the patents Intron Biotechnology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 63 patents it holds.

Back to Intron Biotechnology, Inc.

PatentTitleStatus Expires Confidence
US 8,263,643Polyphenol Compounds with Modulating Neurotransmitter Release
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,505,779Tacrolimus analogues, a neuroprotective composition comprising the same, an immunosuppressive composition comprising the same, a method for preparing the same, and a mutant for producing the same
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,855,253Pharmaceutical composition containing FK506 derivative for treating fungal infection caused by genus Cryptococcus and genus Candida and use thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,226,446FK506 Derivative Maintaining Nerve Regeneration Activity Without Immunosuppressive Activity, and Use Thereof
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,576,060FK506 derivative maintaining nerve regeneration activity without immunosuppressive activity, and use thereof
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,682,333Composition for Inhibiting Formation of Snare Complex, Containing Myricetin Derivatives
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,624,454Hand-packing instrument in the form of gloves
Formerly held
Term ended
Term ended Sep 7, 2026 · From the USPTO record
Term endedTerm ended Sep 7, 2026From the USPTO record
US 11,324,841Metal oxide nanoparticle-based magnetic resonance imaging contrast agent with a central cavity
Lapsed on the fee record
Ended May 10, 2026 · From the USPTO record
Lapsed on the fee recordEnded May 10, 2026From the USPTO record
US 11,219,698Metal oxide nanoparticle-based T1-T2 dual-mode magnetic resonance imaging contrast agent
Lapsed on the fee record
Ended Jan 11, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jan 11, 2026From the USPTO record
US 8,066,990Lysin protein having broad antibacterial activity specific to bacteria
Lapsed on the fee record
Ended Nov 29, 2023 · From the USPTO record
Lapsed on the fee recordEnded Nov 29, 2023From the USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited